1984
DOI: 10.1073/pnas.81.5.1297
|View full text |Cite
|
Sign up to set email alerts
|

Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.

Abstract: The transformation of the antitumor drug N2-methyl-9-hydroxy-ellipticinium by a peroxidase-hydrogen peroxide system, which has been shown to occur in vivo, leads to an electrophilic quinone-imine derivative. This unstable molecule arylates in vitro purine nucleosides and nucdeotides, leading to regioselective adducts substituted ouly at the 2'-O position of the ribose, as shown by mass spectrometry and NMR. It is likely that an important preliminary step in this reaction is a stacking process between the ellip… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

1986
1986
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…e oxidative bioactivation of the antitumor drug 7V2methyl-9-hydroxyellipticinium (NMHE)1 has been found to occur through peroxidase and oxidase reactions leading to the generation of the reactive quinone imine 7V2-methyl-9-oxoellipticinium (NMOE) (Scheme I) (Auclair & Paoletti, 1981;Auclair et al, 1983a;Bernadou et al, 1983). In the presence of suitable nucleophiles such as O, N, or S donor containing compounds, including amino acids, proteins, glutathione, and ribonucleosides, the oxidation of NMHE to NMOE results in the formation of covalent adducts in vitro (Auclair et al, 1983b(Auclair et al, ,c, 1984Meunier et al, 1983;Bernadou et al, 1984).…”
mentioning
confidence: 99%
“…e oxidative bioactivation of the antitumor drug 7V2methyl-9-hydroxyellipticinium (NMHE)1 has been found to occur through peroxidase and oxidase reactions leading to the generation of the reactive quinone imine 7V2-methyl-9-oxoellipticinium (NMOE) (Scheme I) (Auclair & Paoletti, 1981;Auclair et al, 1983a;Bernadou et al, 1983). In the presence of suitable nucleophiles such as O, N, or S donor containing compounds, including amino acids, proteins, glutathione, and ribonucleosides, the oxidation of NMHE to NMOE results in the formation of covalent adducts in vitro (Auclair et al, 1983b(Auclair et al, ,c, 1984Meunier et al, 1983;Bernadou et al, 1984).…”
mentioning
confidence: 99%
“…Recent studies indicate that m-AMSA inhibits the topoisomerization and catenation reactions of DNA topoisomerase II,10 probably by trapping the enzyme-DNA complexes.11, 12 Other substances, such as etoposide (VP- 16, Figure 1), adriamycin, and ellipticine13 also stabilize the cleavable complex between DNA topoisomerase II and DNA. In the present study, we show that the incorporation of an alkylating group into some DNA intercalating agents greatly enhances their antileukemic properties.…”
mentioning
confidence: 99%